Paragraph 8 Amendment of Schedule 4 (periodic fees for licences)

In Schedule 4, in paragraph 1, in the definition of “limited use drug” for “which is in respect of an orphan medicinal product” substitute “in respect of which an orphan marketing authorisation has been granted”.